Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evolysse Sculpt
- Development stage
- Preclinical
- Lead developer
- Symatese
- Administration
- Intradermal, Subcutaneous
01
Overview
Evolysse Sculpt is an injectable hyaluronic acid (HA) dermal filler developed as part of the Evolysse collection, which utilizes proprietary Cold-X Technology. This technology preserves the natural structure of HA molecules by using near-freezing temperatures during manufacturing, resulting in a gel that integrates smoothly into facial tissue for natural-looking volume and contour enhancement. The product is designed to add structure, support, and symmetry to the face, addressing age-related or structural volume loss. As with other products in the Evolysse line, it aims for long-lasting results and high patient satisfaction with a favorable safety profile. The primary indication is aesthetic facial sculpting and volumization[1][6][8].
- Brand names
- Evolysse Sculpt
Beyond the preview
Go deeper on Evolysse Sculpt.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evolysse Sculpt.